Search for: "Medtronic Inc."
Results 581 - 600
of 1,086
Sorted by Relevance
|
Sort by Date
The Paramount Interest in Seeing that Patent Monopolies . . . are Kept Within their Legitimate Scope
31 Jan 2014, 5:05 am
Interesting aspect of the Supreme Court’s decision in Medtronic v. [read post]
26 Jun 2007, 12:54 pm
Under Medtronic, Inc. v. [read post]
22 Jul 2011, 8:44 am
The plaintiffs in PLIVA, Inc. v. [read post]
18 Jun 2018, 8:18 am
Thus, the procedural setup of this case may be contrasted with Medtronic, Inc. v. [read post]
11 Jun 2015, 1:06 pm
Medtronic Inc., 704 F.3d 1224 (9th Cir. 2013); Hughes v. [read post]
24 May 2013, 5:00 am
Medtronic, Inc., 670 F.3d 569 (4th Cir. 2012), Walker also limited the parallel violation exception to Riegel preemption to FDA performance standards applicable to the device. [read post]
1 Jul 2024, 5:30 am
” Indeed, Medtronic, Inc. v. [read post]
15 Aug 2007, 10:01 pm
Medtronic Sofamor Danek, Inc., 424 F.3d 1293, 1311 (Fed. [read post]
10 Mar 2011, 10:50 am
Medtronic, Inc., 623 F.3d 1200 (8th Cir. 2010) (our longer post on Bryant is here). [read post]
2 Sep 2009, 11:22 pm
Medtronic, Inc., 405 F.3d 421, 423-24 (6th Cir. 2005) (preempting "disguised fraud on the FDA claim"); In re Aredia & Zometa Products Liability Litigation, 2009 WL 2497229, at *2 (M.D. [read post]
25 Feb 2014, 6:37 am
Medtronic, Inc., 2013 U.S. [read post]
25 Oct 2011, 7:11 am
Steinbrook notes that conflicts of interest continue as recently reported in The Spine Journal, in connection with a Medtronic clinical trial for recombinant bone morphogenetic protein: “Financial information was available for 12 of the 13 original studies: “the median-known financial associations between the authors and Medtronic Inc were found to be approximately $12,000,000 to $16,000,000 per study (range, $560 000-$23 500 000). [read post]
25 Oct 2011, 7:11 am
Steinbrook notes that conflicts of interest continue as recently reported in The Spine Journal, in connection with a Medtronic clinical trial for recombinant bone morphogenetic protein: “Financial information was available for 12 of the 13 original studies: “the median-known financial associations between the authors and Medtronic Inc were found to be approximately $12,000,000 to $16,000,000 per study (range, $560 000-$23 500 000). [read post]
9 Feb 2012, 8:01 am
The allegations in these settlements all case stem from the government's settlement with Medtronic Spine LLC, the corporate successor to Kyphon, Inc., in 2008. [read post]
19 Oct 2009, 6:07 pm
Medtronic had acquired Kyphon Inc., the seller of kyphoplasty equipment and materials, who promoted the procedure as a moneymaker for hospitals if they billed Medicare for inpatient surgery. [read post]
3 Jan 2011, 11:47 pm
The settlements with these facilities follow the settlements that the government reached in May 2009, September 2009, and May 2010 with 18 other hospitals for kyphoplasty-related Medicare claims, as well as the government’s May 2008 settlement with Medtronic Spine LLC, corporate successor to Kyphon Inc. [read post]
22 Nov 2008, 8:46 pm
In an unusual case the Department of Justice is investigating Medtronic Inc. for the off-label use of its Infuse Bone Graft. [read post]
10 May 2021, 12:25 pm
” Additionally, the U.S. alleged Asfora “solicited and received kickbacks from medical device manufacturer Medtronic USA Inc. [read post]
10 May 2021, 12:25 pm
” Additionally, the U.S. alleged Asfora “solicited and received kickbacks from medical device manufacturer Medtronic USA Inc. [read post]
24 Sep 2007, 9:21 am
The MDA explicitly preempts any “state law requirements” that differ from FDA requirements regarding specific products.In 1996, in Medtronic, Inc. v. [read post]
